ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,022.21
      -0.58%
      US Tech 100
      17,090.00
      0.33%
      Dow Jones
      37,753.31
      -0.12%
      Brent Oil
      86.325
      -0.76%
      Bitcoin
      62,850.62
      2.56%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Viatris Inc (VTRS)

      7. Viatris Inc (VTRS) News

      VTRS Viatris Inc

      11.10
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:19:14
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Viatris Inc VTRS NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 11.10 07:19:14
      Open Price Low Price High Price Close Price Prev Close
      11.10
      more quote information »

      Recent News

      Date Time Source Heading
      4/17/20248:00IHNWFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
      4/16/202416:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
      4/15/202408:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
      4/15/202406:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
      4/01/202406:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
      3/27/202406:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
      3/05/202420:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202420:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
      3/04/202418:11EDGAR2Form 144 - Report of proposed sale of securities
      2/28/202407:39EDGAR2Form 8-K - Current report
      2/28/202406:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
      2/28/202401:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
      2/23/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202417:18EDGAR2Form 144 - Report of proposed sale of securities
      2/05/202406:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
      1/30/202416:40EDGAR2Form 8-K/A - Current report: [Amend]
      1/19/202406:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
      1/05/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202420:28EDGAR2Form 144 - Report of proposed sale of securities
      12/21/202316:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
      12/15/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/15/202317:04EDGAR2Form 8-K/A - Current report: [Amend]
      12/15/202317:00EDGAR2Form 8-K - Current report
      12/15/202316:45PRNUSViatris Continues its Preparations for Phase 2 of its..
      12/15/202316:14EDGAR2Form 8-K - Current report
      12/15/202316:12EDGAR2Form 8-K - Current report
      12/15/202316:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
      12/14/202317:31EDGAR2Form 144 - Report of proposed sale of securities
      11/24/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/24/202316:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      11/24/202313:02EDGAR2Form 144 - Report of proposed sale of securities
      11/14/202308:00PRNUSViatris to Participate in the Jefferies London Healthcare..
      11/13/202308:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
      11/07/202316:39EDGAR2Form 8-K - Current report
      11/07/202316:02PRNUSViatris Reports Strong Financial and Operational Results for..
      11/03/202316:36EDGAR2Form ARS - Annual Report to Security Holders
      11/03/202316:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      11/03/202316:31EDGAR2Form DEF 14A - Other definitive proxy statements
      10/30/202309:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
      10/24/202316:32EDGAR2Form 8-K - Current report
      10/24/202316:30EDGAR2Form PRE 14A - Other preliminary proxy statements
      10/23/202309:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
      10/20/202317:18EDGAR2Form 8-K - Current report
      10/20/202317:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
      10/18/202308:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
      10/10/202309:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..

      Your Recent History

      NASDAQ
      VTRS
      Viatris
      Delayed Upgrade Clock